Posted September 23, 2019
Wang W, Erbe AK, Alderson KA, Phillips E, Gallenberger M,Gan J, Campana D, Hank JA, Sondel PM. NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo expansion. Cancer Immunol Immunother. 2016 Sep;65(9):1047-59.